Zantac Cancer Lawsuit

Popular heartburn drug Zantac may be contaminated with a cancer-causing industrial chemical, NDMA (N-nitrosodimethylamine). People who were diagnosed with stomach, kidney, bladder, colon or pancreatic cancer may be filing Zantac lawsuits.

Free Case Evaluation

Zantac Cancer Lawsuit Investigation

The FDA recently warned that Zantac and generic products containing heartburn medication, ranitidine, may be contaminated with cancer-causing agent NDMA (N-nitrosodimethylamine). NDMA is a chemical normally found in petroleum-based products such as gasoline, rocket fuel and industrial lubricants.

People who took Zantac and developed cancer may be filing lawsuits against Sanofi-Aventis, Zantac’s manufacturer or generic suppliers. Those who may be eligible for compensation from a Zantac lawsuit include:

Those who took prescription or OTC Zantac medication regularly for at least 60 days and were diagnosed with:

  • Stomach or gastric cancer
  • Kidney cancer
  • Bladder cancer
  • Pancreatic cancer
  • Colon cancer

If cancer was diagnosed more than 6 months after Zantac use was discontinued, it must have been taken regularly for more than 1 year.

Some pharmacies including large chain drugstores and big-box stores like CVS, Walgreens, Walmart and others may be pulling Zantac and store brand ranitidine products of their shelves over concerns about cancers caused by the medications.

FDA Zantac Contamination Warning

European and U.S. health agencies including the U.S. Food and Drug Administration (FDA) are warning that popular heartburn drug Zantac, and other generic formulations of over-the-counter acid-reducers containing the ingredient ranitidine, may be contaminated a cancer-causing agent, N-nitrosodimethylamine (NDMA).

NDMA is a semi-volatile organic compound used as a stabilizer in gasoline, rocket fuel and other petroleum-based industrial products and is a byproduct of pesticide manufacturing and other industries. NDMA is a known human carcinogen according to the U.S. Environmental Protection Agency (EPA).

NDMA is a known environmental contaminant that is sometimes found in water and foods. NDMA levels in Zantac and ranitidine products have been found to be 3,000 to 26,000 times higher than legally allowed levels which were set by the FDA.

Previous NDMA Contamination of Drugs

Recently, other medications including the prescription high blood pressure medication, Diovan or valsartan, has been under investigation for similar contamination with NDMA. The FDA has required that a number of similar Angiotensin II Receptor Blockers (ARBs) be recalled for contamination with NDMA and similar chemicals.

All ARB contamination appears to have originated at pharmaceutical ingredient manufacturing plants in China and India. No link with Zantac or ranitidine contamination has been established yet.

Zantac and Ranitidine Recalls

Though Zantac’s manufacturer has made no comment, another drug-maker, Novartis-AG Sandoz has issued a voluntary recall of ranitidine capsules due to an “elevated amount of unexpected impurity” and has stopped sales of generic medications containing ranitidine in the U.S. and Canada. Other generic manufacturers including Apotex and GlaxoSmithKline are recalling ranitidine products in the U.S. Hong Kong and India.

The FDA has not yet issued instructions that people discontinue taking the medication but a number of pharmacies, chain drugstores and big-box stores are pulling Zantac and store-brand generics off of their shelves. CVS, Walgreens and Walmart are some of the notable retailers that are discontinuing Zantac and ranitidine products until further notice.

Health experts have noted that patients have a number of alternatives when taking medication for reflux or heartburn and should seek a recommendation from their healthcare practitioner before discontinuing medication.

Carcinogenic Zantac Effects

Though health experts have stated that the short-term risk of NDMA-caused cancer from medication use may be low, longer term exposure has not been fully evaluated. NDMA, however has been shown to be a potent carcinogen in other industries.

Potential carcinogenic effects of NDMA exposure include:

  • Stomach cancer
  • Bladder cancer
  • Kidney cancer
  • Intestinal cancer
  • Colon cancer
  • Pancreatic cancer

Filing a Zantac Cancer Lawsuit

People who have been diagnosed or developed cancer after taking Zantac or medications containing ranitidine may be eligible for compensation. Eligibility for filing a Zantac lawsuit include those who used Zantac regularly for over 60 days and were diagnosed with:

  • Stomach or gastric cancer
  • Colon or intestinal cancer
  • Bladder cancer
  • Kidney cancer
  • Pancreatic cancer

People whose cancer diagnosis occurred more than 6 months after discontinuing ranitidine use, must have taken brand-name prescription or over-the-counter Zantac regularly for more than 1 year.

Zantac contamination lawsuits may provide compensation for damages including:

  • Past and future medical costs
  • Lost wages
  • Pain and suffering
  • Temporary or permanent disability
  • Punitive damages
  • Wrongful death

People or loved ones of those who may have developed cancer due to Zantac contamination should seek advice from legal experts.

Contact Seeger Weiss for a free case evaluation, or call 888-610-6574.



Since its establishment in 1999, Seeger Weiss has led some of the most complex and high-profile litigations in the U.S.